{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:37:44Z","timestamp":1789349864759,"version":"build-2803163510"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108961","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T19:41:58Z","timestamp":1412106118000},"page":"e108961","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6\/2 Mouse Model"],"prefix":"10.1371","volume":"9","author":[{"given":"Michal","family":"Mielcarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie K.","family":"Bondulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Inuabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bates GP, Tabrizi SJ, Jones AL (2014) Huntington's Disease. New York: Oxford University Press.","DOI":"10.1093\/med\/9780199929146.001.0001"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"TV Strong","year":"1993","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","article-title":"Huntington's disease: the current state of research with peripheral tissues","volume":"219","author":"J Sassone","year":"2009","journal-title":"Exp Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"JM van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntington's disease gene (IT15) is widely expressed in human and rat tissues","volume":"11","author":"SH Li","year":"1993","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1074\/jbc.M511007200","article-title":"Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein","volume":"281","author":"W Li","year":"2006","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"P Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jmg.29.12.911","article-title":"Causes of death in patients with Huntington's disease and in unaffected first degree relatives","volume":"29","author":"SA Sorensen","year":"1992","journal-title":"J Med Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5694\/j.1326-5377.1982.tb132224.x","article-title":"Causes of death in Huntington's disease","volume":"1","author":"E Chiu","year":"1982","journal-title":"Med J Aust"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.38.5.769","article-title":"Huntington's disease mortality in the United States","volume":"38","author":"DJ Lanska","year":"1988","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"JS Pattison","year":"2008","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"CH Lin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1004550","DOI":"10.1371\/journal.pgen.1004550","article-title":"Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease","volume":"10","author":"M Mielcarek","year":"2014","journal-title":"PLoS Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","article-title":"Cardiac dysfunction in the R6\/2 mouse model of Huntington's disease","volume":"25","author":"MJ Mihm","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","article-title":"Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease","volume":"590","author":"H Kiriazis","year":"2012","journal-title":"J Physiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1004024","DOI":"10.1371\/journal.pgen.1004024","article-title":"Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart","volume":"9","author":"GC Melkani","year":"2013","journal-title":"PLoS Genet"},{"key":"ref19","first-page":"H638","article-title":"Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart","volume":"269","author":"MO Boluyt","year":"1995","journal-title":"Am J Physiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system","volume":"37","author":"D Grimm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"H1593","DOI":"10.1152\/ajpheart.00985.2006","article-title":"Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and beta-adrenergic desensitization","volume":"292","author":"YT Jin","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"30800","DOI":"10.1074\/jbc.M400154200","article-title":"Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes","volume":"279","author":"HH Chen","year":"2004","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gep.2008.12.002","article-title":"VITO-2, a new SID domain protein, is expressed in the myogenic lineage during early mouse embryonic development","volume":"9","author":"M Mielcarek","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/nar\/gkh248","article-title":"VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation","volume":"32","author":"S Gunther","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1016\/S0925-4773(03)00127-8","article-title":"VITO-1, a novel vestigial related protein is predominantly expressed in the skeletal muscle lineage","volume":"119 Suppl 1","author":"M Mielcarek","year":"2002","journal-title":"Mech Dev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease","volume":"3","author":"CL Benn","year":"2008","journal-title":"Mol Neurodegener"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.83.1.43","article-title":"Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes","volume":"83","author":"AF Stewart","year":"1998","journal-title":"Circ Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13721","DOI":"10.1074\/jbc.M109.063057","article-title":"TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction","volume":"285","author":"RW Tsika","year":"2010","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-2828(03)00049-X","article-title":"Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites","volume":"35","author":"BG McLean","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2010.02.014","article-title":"Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment","volume":"62","author":"C Colussi","year":"2010","journal-title":"Pharmacol Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"TA McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14728220902939161","article-title":"Targeting histone deacetylases for heart failure","volume":"13","author":"EW Bush","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"28930","DOI":"10.1074\/jbc.M303113200","article-title":"Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors","volume":"278","author":"CL Antos","year":"2003","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop","volume":"112","author":"H Kook","year":"2003","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"HJ Kee","year":"2006","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.1074\/jbc.M710277200","article-title":"HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity","volume":"283","author":"MP Gupta","year":"2008","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"RL Montgomery","year":"2008","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","article-title":"HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats","volume":"56","author":"JP Cardinale","year":"2010","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"A Granger","year":"2008","journal-title":"FASEB J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","article-title":"Inhibition of histone deacetylase on ventricular remodeling in infarcted rats","volume":"293","author":"TM Lee","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"26484","DOI":"10.1074\/jbc.M803686200","article-title":"Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy","volume":"283","author":"CM Trivedi","year":"2008","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"S Chang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"CL Zhang","year":"2002","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.RES.0000147557.75257.ff","article-title":"Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes","volume":"95","author":"RR Alcendor","year":"2004","journal-title":"Circ Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"E Hockly","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington's disease","volume":"19","author":"K Sathasivam","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e80849","DOI":"10.1371\/journal.pone.0080849","article-title":"HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo","volume":"8","author":"M Mielcarek","year":"2013","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1001717","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration","volume":"11","author":"M Mielcarek","year":"2013","journal-title":"PLoS Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e27746","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"M Mielcarek","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T05:43:15Z","timestamp":1598334195000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108961"}},"subtitle":[],"editor":[{"given":"Xiao-Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108961","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]}}}